Safety issues related to the administration of ribavirin

Pediatr Infect Dis J. 2002 May;21(5):479-81. doi: 10.1097/00006454-200205000-00037.
No abstract available

Publication types

  • Review

MeSH terms

  • Abnormalities, Drug-Induced*
  • Absorption
  • Administration, Inhalation
  • Adult
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / pharmacokinetics
  • Antiviral Agents / therapeutic use
  • Child
  • Child, Preschool
  • Female
  • Health Personnel*
  • Humans
  • Infant
  • Infant, Newborn
  • Inhalation Exposure
  • Occupational Exposure*
  • Pregnancy
  • Respiratory Protective Devices
  • Respiratory Syncytial Virus Infections / drug therapy*
  • Ribavirin / adverse effects*
  • Ribavirin / pharmacokinetics
  • Ribavirin / therapeutic use
  • Risk Assessment
  • Teratogens

Substances

  • Antiviral Agents
  • Teratogens
  • Ribavirin